Close X
my esmo
 
Username: Password:
Remember me!


Forgot your Password? Create an account

Use of the ESMO services is subject to the Terms & Conditions and constitutes your agreement to abide by these.

Close X
my esmo
 
Username: Password:
Remember me!


Forgot your Password? Create an account

Use of the ESMO services is subject to the Terms & Conditions and constitutes your agreement to abide by these.

TRU visit reports

Period

Institute

Where

Topic

24-27 April, 2012 Southern Sweden Cancer Center Lund, Sweden Translational Oncology - from bioinformatics to clinical informatics; focus on hereditary, breast cancer, melanoma and sarcoma
6-9 February, 2012 Institute Gustave Roussy Villejuif, France Integration of molecular medicine into clinical trials. The report will be available after the visit
12-14 October, 2011 The European Institute of Oncology Milan, Italy Circulating endothelial cells and progenitors as biomarkers in anti-angiogenic therapy of cancer
10-13 October, 2011 Oncology Institute of Southern Switzerland (IOSI) Bellinzona, Switzerland Translational studies and new drug development in Oncology: The importance of the laboratory-clinical interface.
27-29 April, 2011 Vall d'Hebron Barcelona, Spain An introduction to Translational Research in Oncology
November 2-4, 2010

Radboud University Nijmegen Medical Center

Nijmegen, The Netherlands

New avenues in Translational Research:

27th to 29th October, 2010 The Molekulare Krebsforschungszentrum of the Charité Berlin, Germany Translational cancer research: the laboratory-clinical interface at the MKFZ
29 March to
1 April 2010
University Medical Center Groningen (UMCG) Groningen, The Netherlands Translational Research illustrated through the following themes: Molecular imaging, Long term toxicity and early (pre)clinical trials, Microenvironment, infiltration and metastasis of tumor cells and several aspects of gynaecological oncology trials
27-30 October, 2009 Institute Curie Paris, France Translational Research in Breast Cancer
Including: Tumor profiling, circulating tumor cells and disseminated tumor cells: detection, prognostic value, potential marker to monitor the efficacy of treatment, clinical grafts: a tool for defining new drugs association and new targets, epigenetic in Breast cancers, hereditary breast cancers
23-25 March, 2009 Jules Bordet Institute

Brussels, Belgium

Integrating tumor profiling, tumor microenvironment and minimal residual disease to predict clinical outcome and response to various therapeutics in breast cancer patients.
6-9 October, 2008 Instituto Nazionale Tumori Milan, Italy Soft tissue sarcomas, GIST and melanoma.
21-24 April, 2008 I.O.S.I. Bellinzona, Switzerland Translational studies and new drug development in Oncology: the laboratory-clinical interface.
16-19 April, 2007 Norwegian Radium Hospital Oslo, Norway New avenues in molecular diagnostics, immunotherapy, micro-metastases and tumor stem cells.
14-16 February, 2007 Vall d'Hebron Hospital Barcelona, Spain Early Clinical Development of Molecular Targeted Therapies.
23-26 March, 2006 Institut Gustave Roussy Villejuif, France How to succeed in translational research.
21-24 February 2006 Cancer Centre Karolinska Stockholm, Sweden Tumor immunology and immunotherapy.
13-15 April, 2005 Vall d'Hebron Hospital Barcelona, Spain Early Clinical Development of Molecular Targeted Therapies.
23-25 February, 2005 Radcliffe Infirmary Oxford, UK Gene Therapy for Cancer.
21-23 April, 2004 Karolinska Institute Stockholm, Sweden Tumor immunology and immunotherapy.